MCM
BIIB icon

Mazama Capital Management’s Biogen BIIB Stock Holding History

Mazama Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,383
Closed -$4.1M – 22
2015
Q4 		$4.1M Buy
13,383
+8,203
+158% +$2.36M 0.75% 39
2015
Q3 		$1.51M Buy
+5,180
New +$1.71M 0.31% 78
2015
Q2 		– Sell
-13,057
Closed -$5.51M – 286
2015
Q1 		$5.51M Buy
13,057
+5,132
+65% +$2.02M 1.13% 21
2014
Q4 		$2.69M Buy
+7,925
New +$2.56M 0.62% 54
2014
Q2 		– Sell
-143
Closed -$44K – 274
2014
Q1 		$44K Buy
143
+1
+0.7% +$317 0.04% 157
2013
Q4 		$40K Buy
+142
New +$36.7K 0.02% 190

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mazama Capital Management's BIIB Position: Q1 2016 in Review

Mazama Capital Management sold out of Biogen (BIIB) in Q1 2016, closing a stake of 13,383 shares — an estimated $4.1M sold.

Mazama Capital Management first reported a position in BIIB in Q4 2013 and held it in 6 quarters. The position peaked at $5.51M in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Mazama Capital Management reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Mazama Capital Management sold 13,383 Biogen shares in Q1 2016, an estimated $4.1M.
  • Mazama Capital Management first reported a position in Biogen in Q4 2013 and held it in 6 quarters.
  • Mazama Capital Management's Biogen position peaked at $5.51M in Q1 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.